Long Dai

Dr. Long Dai


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JSJing Song
Jing Song
GHGuan-Nan He
Guan-Nan He
LDLong Dai
Long Dai
Celastrol, triptolide and triptonide are the most significant active ingredients of Tripterygium wilfordii Hook F (TWHF). In 2007, the 'Cell' journal ranked celastrol, triptolide, artemisinin, capsaicin and curcumin as the five natural drugs that can be developed into modern medicinal compounds. In this review, we collected relevant data from the Web of Science, PubMed and China Knowledge Resource Integrated databases. Some information was also acquired from government reports and conference papers. Celastrol, triptolide and triptonide have potent pharmacological activity and evident anti-cancer, anti-tumor, anti-obesity and anti-diabetes effects. Because these compounds have demonstrated unique therapeutic potential for acute and chronic inflammation, brain injury, vascular diseases, immune diseases, renal system diseases, bone diseases and cardiac diseases, they can be used as effective drugs in clinical practice in the future. However, celastrol, triptolide and triptonide have certain toxic effects on the liver, kidney, cholangiocyte heart, ear and reproductive system. These shortcomings limit their clinical application. Suitable combination therapy, new dosage forms and new routes of administration can effectively reduce toxicity and increase the effect. In recent years, the development of different targeted drug delivery formulations and administration routes of celastrol and triptolide to overcome their toxic effects and maximise their efficacy has become a major focus of research. However, in-depth investigation is required to elucidate the mechanisms of action of celastrol, triptolide and triptonide, and more clinical trials are required to assess the safety and clinical value of these compounds.

21 October 2022 in Food Chemistry
Verified
Journal Article
Closed access
ZXZedong Xiang
Zedong Xiang
QXQing Xue
Qing Xue
PGPeng Gao
Peng Gao
HYHaitao Yu
Haitao Yu
MWMingze Wu
Mingze Wu
LDLong Dai
Long Dai

6 June 2025 in Food Chemistry
Verified
Journal Article
Closed access
JSJiteng Sun
Jiteng Sun
YCYanli Chen
Yanli Chen
YYYue Yang
Yue Yang
HCHaixia Chen
Haixia Chen
JZJiayu Zhang
Jiayu Zhang
LDLong Dai
Long Dai

28 January 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
HCHaixia Chen
Haixia Chen
YWYumin Wei
Yumin Wei
JSJing Song
Jing Song
YYYue Yang
Yue Yang
YCYanli Chen
Yanli Chen
YLYanan Li
Yanan Li
In traditional Chinese medicine theory, Scutellaria baicalensis Georgi [Lamiaceae; Scutellariae radix] (SR) is bitter and cold in nature. It enters the lung, gallbladder, spleen, large intestine, and small intestine meridians. It clears heat and dries dampness, purges fire and detoxifies, stops bleeding, and stabilizes pregnancy. It excels at clearing lung fire and upper-body heat. Flavonoids, the primary active compound of SR, undergo metabolism in vivo through Phase I and Phase II reactions as well as intestinal flora-mediated processes. Modern pharmacological research indicates that flavonoid compounds exhibit diverse biological activities in immune modulation, antiviral, anti-inflammatory, antibacterial, and antitumor effects. In recent years, novel formulations such as nanomedicines and liposomes have garnered increasing attention to enhance their stability and bioavailability. This review systematically summarizes the research progress on flavonoid compounds in SR, comprehensively elaborating on their phytochemistry, extraction methods, separation and purification techniques, in vivo metabolism, immunological and pharmacological effects, toxicity, and novel dosage forms. It provides theoretical foundations and practical references for the further research, development, and rational application of these compounds.

8 July 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YYYue Yang
Yue Yang
HCHaixia Chen
Haixia Chen
JSJiteng Sun
Jiteng Sun
YCYanli Chen
Yanli Chen
DBDaoming Bai
Daoming Bai
LDLong Dai
Long Dai

12 October 2023 in Molecules
Verified
Journal Article
Open access
PDF file
YLYanan Li
Yanan Li
PDPingping dong
Pingping dong
LDLong Dai
Long Dai
SWshaoping wang
shaoping wang
The active peptide (APE) of Eupolyphaga sinensis Walker, which is prepared by bioenzymatic digestion, has significant antihyperlipidemic effects in vivo, but its mechanism of action on hyperlipidemia is not clear. Recent studies on amino acid metabolism suggested a possible link between it and hyperlipidemia. In this study, we first characterized the composition of APE using various methods. Then, the therapeutic effects of APE on hyperlipidemic rats were evaluated, including lipid levels, the inflammatory response, and oxidative stress. Finally, the metabolism-regulating mechanisms of APE on hyperlipidemic rats were analyzed using untargeted and targeted metabolomic approaches. The results showed that APE significantly reduced the accumulation of fat, oxidative stress levels, and serum pro-inflammatory cytokine levels. Untargeted metabolomic analysis showed that the mechanism of the hypolipidemic effect of APE was mainly related to tryptophan metabolism, phenylalanine metabolism, arginine biosynthesis, and purine metabolism. Amino-acid-targeted metabolomic analysis showed that significant differences in the levels of eight amino acids occurred after APE treatment. Among them, the expression of tryptophan, alanine, glutamate, threonine, valine, and phenylalanine was upregulated, and that of arginine and proline was downregulated in APE-treated rats. In addition, APE significantly downregulated the mRNA expression of SREBP-1, SREBP-2, and HMGCR. Taking these points together, we hypothesize that APE ameliorates hyperlipidemia by modulating amino acid metabolism in the metabolome of the serum and feces, mediating the SREBP/HMGCR signaling pathway, and reducing oxidative stress and inflammation levels.